1. Home
  2. SLNO vs ADEA Comparison

SLNO vs ADEA Comparison

Compare SLNO & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$52.63

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Adeia Inc.

ADEA

Adeia Inc.

HOLD

Current Price

$27.28

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNO
ADEA
Founded
1999
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.3B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
SLNO
ADEA
Price
$52.63
$27.28
Analyst Decision
Buy
Strong Buy
Analyst Count
9
4
Target Price
$90.13
$31.00
AVG Volume (30 Days)
5.5M
1.0M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
0.75%
EPS Growth
108.90
73.68
EPS
0.39
0.99
Revenue
$1,450,788.00
$443,386,000.00
Revenue This Year
$151.77
N/A
Revenue Next Year
$53.58
$5.63
P/E Ratio
$134.99
$27.06
Revenue Growth
138.82
17.91
52 Week Low
$29.43
$11.53
52 Week High
$89.12
$27.59

Technical Indicators

Market Signals
Indicator
SLNO
ADEA
Relative Strength Index (RSI) 77.58 72.29
Support Level $48.91 $16.21
Resistance Level $55.47 N/A
Average True Range (ATR) 1.49 0.99
MACD 2.06 0.12
Stochastic Oscillator 99.72 97.71

Price Performance

Historical Comparison
SLNO
ADEA

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About ADEA Adeia Inc.

Adeia Inc is a consumer and entertainment product/solutions licensing company. It's the only operating segment, being Intellectual Property (IP) Licensing. In the IP segment, the company licenses innovations to companies in the broader entertainment industry and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.

Share on Social Networks: